Allevi, Inc. — Form D
Allevi, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-30. The offering totals $2.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-10-30
- Form: D
- Accession: 0001650661-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.0M
- Remaining: $996K
- Minimum investment: $25K
- Investors: 5
- Date of first sale: 2019-10-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-352191
Issuer
- Name: Allevi, Inc.
- CIK: 0001650661
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 3401 GRAYS FERRY AVENUE, BUILDING 176, PHILADELPHIA, PA, 19146
- Phone: 305-742-3311
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Evangeline Gonzalez | Director | Philadelphia, PA |
| David Joseph | Director | Milwaukee, WI |
| Angelo Masciantonio | Director | Philadelphia, PA |
| Frank McCaney | Director | Philadelphia, PA |
| Ricardo Solorzano | Director | Philadelphis, PA |
| Madeline Winter | Director | Philadelphia, PA |
| Ricardo Solorzano | Executive Officer | Philadelphis, PA |
| Madeline Winter | Executive Officer | Philadelphia, PA |
| Daniel Cabrera | Director | Philadelphia, PA |
| Daniel Cabrera | Executive Officer | Philadelphia, PA |
Other filings by this issuer (2)
More